|
Volumn 19, Issue 10, 1998, Pages 406-415
|
Steroidal and nonsteroidal oestrogen antagonists in breast cancer: Basic and clinical appraisal
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
4 HYDROXYTAMOXIFEN;
ANTIESTROGEN;
DROLOXIFENE;
ESTROGEN;
ESTROGEN RECEPTOR;
FULVESTRANT;
IDOXIFENE;
N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE;
NORTAMOXIFEN;
PARTIAL AGONIST;
RALOXIFENE;
SEX HORMONE;
STEROID;
TAMOXIFEN;
TOREMIFENE;
BREAST CANCER;
CANCER GROWTH;
CLINICAL TRIAL;
DRUG ABSORPTION;
DRUG ANTAGONISM;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG RECEPTOR BINDING;
DRUG SYNTHESIS;
HUMAN;
LIVER CARCINOGENESIS;
LIVER METABOLISM;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
PROTEIN CONFORMATION;
RECEPTOR BLOCKING;
REVIEW;
SIDE EFFECT;
BREAST NEOPLASMS;
DRUG RESISTANCE, NEOPLASM;
ESTROGEN ANTAGONISTS;
FEMALE;
HUMANS;
MOLECULAR STRUCTURE;
TAMOXIFEN;
|
EID: 0032191125
PISSN: 01656147
EISSN: None
Source Type: Journal
DOI: 10.1016/S0165-6147(98)01252-8 Document Type: Review |
Times cited : (48)
|
References (94)
|